These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24513044)

  • 1. Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent.
    Jeon YT; Yang W; Qiao JX; Li L; Ruel R; Thibeault C; Hiebert S; Wang TC; Wang Y; Liu Y; Clark CG; Wong HS; Zhu J; Wu DR; Sun D; Chen BC; Mathur A; Chacko SA; Malley M; Chen XQ; Shen H; Huang CS; Schumacher WA; Bostwick JS; Stewart AB; Price LA; Hua J; Li D; Levesque PC; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1294-8. PubMed ID: 24513044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.
    Qiao JX; Wang TC; Ruel R; Thibeault C; L'Heureux A; Schumacher WA; Spronk SA; Hiebert S; Bouthillier G; Lloyd J; Pi Z; Schnur DM; Abell LM; Hua J; Price LA; Liu E; Wu Q; Steinbacher TE; Bostwick JS; Chang M; Zheng J; Gao Q; Ma B; McDonnell PA; Huang CS; Rehfuss R; Wexler RR; Lam PY
    J Med Chem; 2013 Nov; 56(22):9275-95. PubMed ID: 24164581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubility.
    Wang TC; Qiao JX; Clark CG; Jua J; Price LA; Wu Q; Chang M; Zheng J; Huang CS; Everlof G; Schumacher WA; Wong PC; Seiffert DA; Stewart AB; Bostwick JS; Crain EJ; Watson CA; Rehfuss R; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3239-43. PubMed ID: 23602442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Aminothiazole based P2Y(1) antagonists as novel antiplatelet agents.
    Pi Z; Sutton J; Lloyd J; Hua J; Price L; Wu Q; Chang M; Zheng J; Rehfuss R; Huang CS; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4206-9. PubMed ID: 23743287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists.
    Chao H; Turdi H; Herpin TF; Roberge JY; Liu Y; Schnur DM; Poss MA; Rehfuss R; Hua J; Wu Q; Price LA; Abell LM; Schumacher WA; Bostwick JS; Steinbacher TE; Stewart AB; Ogletree ML; Huang CS; Chang M; Cacace AM; Arcuri MJ; Celani D; Wexler RR; Lawrence RM
    J Med Chem; 2013 Feb; 56(4):1704-14. PubMed ID: 23368907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents.
    Yang W; Wang Y; Lai A; Qiao JX; Wang TC; Hua J; Price LA; Shen H; Chen XQ; Wong P; Crain E; Watson C; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
    J Med Chem; 2014 Jul; 57(14):6150-64. PubMed ID: 24931384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds.
    Ruel R; L'Heureux A; Thibeault C; Lapointe P; Martel A; Qiao JX; Hua J; Price LA; Wu Q; Chang M; Zheng J; Huang CS; Wexler RR; Rehfuss R; Lam PY
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6825-8. PubMed ID: 24269480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distribution.
    Qiao JX; Wang TC; Hiebert S; Hu CH; Schumacher WA; Spronk SA; Clark CG; Han Y; Hua J; Price LA; Shen H; Chacko SA; Everlof G; Bostwick JS; Steinbacher TE; Li YX; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
    ChemMedChem; 2014 Oct; 9(10):2327-43. PubMed ID: 24989964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y
    Peng J; Zhao L; Wang L; Chen H; Qiu Y; Wang J; Yang H; Liu J; Liu H
    Eur J Med Chem; 2018 Oct; 158():302-310. PubMed ID: 30223118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y
    Lei Y; Zhang B; Liu D; Zhao J; Dai X; Gao J; Mao Q; Feng Y; Zhao J; Lin F; Duan Y; Zhang Y; Bao Z; Yang Y; Mou Y; Wang S
    J Med Chem; 2020 Dec; 63(24):15752-15772. PubMed ID: 33307675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel.
    Caroff E; Hubler F; Meyer E; Renneberg D; Gnerre C; Treiber A; Rey M; Hess P; Steiner B; Hilpert K; Riederer MA
    J Med Chem; 2015 Dec; 58(23):9133-53. PubMed ID: 26550844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.
    Yanachkov IB; Chang H; Yanachkova MI; Dix EJ; Berny-Lang MA; Gremmel T; Michelson AD; Wright GE; Frelinger AL
    Eur J Med Chem; 2016 Jan; 107():204-18. PubMed ID: 26588064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonists.
    Thalji RK; Aiyar N; Davenport EA; Erhardt JA; Kallal LA; Morrow DM; Senadhi S; Burns-Kurtis CL; Marino JP
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4104-7. PubMed ID: 20542694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New azole antagonists with high affinity for the P2Y(1) receptor.
    Ruel R; L'Heureux A; Thibeault C; Daris JP; Martel A; Price LA; Wu Q; Hua J; Wexler RR; Rehfuss R; Lam PY
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3519-22. PubMed ID: 23668989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of 2-phenyl-pyrimidine-4-carboxamides towards potent, orally bioavailable and selective P2Y(12) antagonists for inhibition of platelet aggregation.
    Caroff E; Meyer E; Treiber A; Hilpert K; Riederer MA
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4323-31. PubMed ID: 25113932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
    Parlow JJ; Burney MW; Case BL; Girard TJ; Hall KA; Hiebsch RR; Huff RM; Lachance RM; Mischke DA; Rapp SR; Woerndle RS; Ennis MD
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4657-63. PubMed ID: 19604694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of P2Y
    Kong D; Xue T; Guo B; Cheng J; Liu S; Wei J; Lu Z; Liu H; Gong G; Lan T; Hu W; Yang Y
    J Med Chem; 2019 Mar; 62(6):3088-3106. PubMed ID: 30843696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists.
    Hu CH; Qiao JX; Han Y; Wang TC; Hua J; Price LA; Wu Q; Shen H; Huang CS; Rehfuss R; Wexler RR; Lam PY
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2481-5. PubMed ID: 24767843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of cyclopentyl-triazolol-pyrimidine (CPTP) based P2Y12 antagonists.
    Tu W; Fan J; Zhang H; Xu G; Liu Z; Qu J; Yang F; Zhang L; Luan T; Yuan J; Gong A; Feng J; Sun P; Dong Q
    Bioorg Med Chem Lett; 2014 Jan; 24(1):141-6. PubMed ID: 24332627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
    Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
    Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.